Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Qingwei Zhu"'
Autor:
Zibo Yuan1,2 dshuang@hmc.edu.cn, Qingwei Zhu1,2, Qingsong Wu3, Zhe Zhang3, Junwei Guo3, Gongqiang Wu4, Cuiping Zheng5, Qiuran Xu2, Dongsheng Huang2, Di Cui2,6 cuidi@hmc.edu.cn
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 9, p2580-2600. 21p.
Autor:
Qingsong Wu, Yuanyuan Qiu, Jinhui Guo, Zibo Yuan, Yingnan Yang, Qingwei Zhu, Zhe Zhang, Junwei Guo, Yanfang Wu, Junyu Zhang, Dongsheng Huang, Kangsheng Tu, Xiaoge Hu
Publikováno v:
Biology Direct, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Hepatocellular carcinoma (HCC) is a prevalent malignant tumor that poses a major threat to people’s lives and health. Previous studies have found that multiple deubiquitinating enzymes are involved in the pathogenesis of HCC. Th
Externí odkaz:
https://doaj.org/article/b236f9e047f045c6ad545aea5fd3aa3e
Autor:
Haoge Geng, Jiayu Chen, Kangsheng Tu, Hang Tuo, Qingsong Wu, Jinhui Guo, Qingwei Zhu, Zhe Zhang, Yujie Zhang, Dongsheng Huang, Mingzhen Zhang, Qiuran Xu
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Hepatic ischemia-reperfusion injury (HIRI) is a pathophysiological process during liver transplantation, characterized by insufficient oxygen supply and subsequent restoration of blood flow leading to an overproduction of reactive
Externí odkaz:
https://doaj.org/article/9f6bbe4ecad54177b082a14a68ffd3e4
Autor:
Dandan Gao, Qiangyi Zhou, Dianqi Hou, Xiaoqing Zhang, Yiqin Ge, Qingwei Zhu, Jian Yin, Xiangqian Qi, Yaohua Liu, Meiqing Lou, Li Zhou, Yunke Bi
Publikováno v:
PeerJ, Vol 12, p e16874 (2024)
Low-grade glioma (LGG), a common primary tumor, mainly originates from astrocytes and oligodendrocytes. Increasing evidence has shown that peroxisomes function in the regulation of tumorigenesis and development of cancer. However, the prognostic valu
Externí odkaz:
https://doaj.org/article/e1101c8670c644159f329f04b497971f
Autor:
Qingwei Zhu, Wei Rao, Junyu Huo, Zixiang Li, Song Wang, Wensheng Qiu, Ge Guan, Yang Xin, Ning Fan, Jinzhen Cai, Liqun Wu
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Regorafenib is an oral multikinase inhibitor and became the first second-line systemic treatment for hepatocellular carcinoma (HCC) following the phase III RESORCE trial. This single-center study retrospectively analyzed the clini
Externí odkaz:
https://doaj.org/article/91f39d70db7f42acb70a529bd101cf18
Autor:
FuMing Yang, YunKe Bi, QiangYi Zhou, HongChan Li, YaJun Xue, QingWei Zhu, Jian Yin, ZhiYu Wang, MeiQing Lou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesTo understand the different characteristics and growth corridors of knosp grade 4 pituitary adenomas (Knosp4PA) with cavernous sinus (CS) compartments penetration and intracranial extension, aiming to improve the safety, effectiveness, and
Externí odkaz:
https://doaj.org/article/6602e86ac8a542eba57f71a3cfbd686d
Autor:
Houshi Xu, Anke Zhang, Chaoyou Fang, Qingwei Zhu, Wei Wang, Yibo Liu, Zeyu Zhang, Xiaoyu Wang, Ling Yuan, Yuanzhi Xu, Anwen Shao, Meiqing Lou
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundGlioma is a fatal tumor originating from the brain, which accounts for most intracranial malignancies. Currently, Immunotherapy has turned into a novel and promising treatment in glioma patients. however, there are still few effective bioma
Externí odkaz:
https://doaj.org/article/6b5bed9dc880480793b2556e6a87e998
Publikováno v:
Ecological Indicators, Vol 144, Iss , Pp 109462- (2022)
Many studies have reported the influence of dispersal processes on aquatic bacterial communities, but the role of community coalescence is still unknown in sediment-laden rivers. Here, we examined the assembly of distinctive bacterial communities (fr
Externí odkaz:
https://doaj.org/article/07dc213b9b1a493d9a6a60d11709340d
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Purpose Glioma is the most prevalent malignant form of brain tumors, with a dismal prognosis. Currently, cancer immunotherapy has emerged as a revolutionary treatment for patients with advanced highly aggressive therapy-resistant tumors. How
Externí odkaz:
https://doaj.org/article/408091f2b50448f28d8b3ca66fae7784
Autor:
Yunke Bi, Yunjia Ni, Dandan Gao, Qingwei Zhu, Qiangyi Zhou, Junjia Tang, Juan Liu, Fei Shi, Hongchan Li, Jian Yin, Yaohua Liu, Meiqing Lou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/e08fde8fce824317873c923025665157